PACS1 and cancer: Recently, Veena et al.2 found that PACS1, which is the direct target of miR-34a and miR-449a is upregulated in HeLa cells and promotes cancer progression while observing the decreased expression of miR-34a and miR-449a in the HeLa cells, simultaneously.